The global coronavirus immunoassay industry size has exhibited remarkable growth, hitting a substantial mark of US$ 3.7 Billion in 2021. According to recent market analyses, this thriving sector is poised for further expansion, foreseeing a robust Compound Annual Growth Rate (CAGR) of 5.5% over the assessment period. Projections suggest an impressive escalation, with the market anticipated to …
Category Archives: Healthcare Trends
Global Heart Block Therapeutics Industry is poised for a 4.3% CAGR by 2032, highlighting its promising future as forecasted by FMI
The global heart block therapeutics industry demand, which surged to an estimated US$ 3.1 Billion in 2022, is poised for substantial growth, according to recent insights from Future Market Insights. The market’s expansion is driven by increased investments and growing expenditure in Heart Block Therapeutics worldwide. With a projected Compound Annual Growth Rate (CAGR) of 4.3% …
Global Systemic Lupus Erythematous Drugs Industry gears up for a substantial rise, forecasted to attain US$ 329.18 Billion by 2032 | FMI
The global systemic lupus erythematous drugs industry size is on a trajectory of significant growth, poised to witness a steady ascent over the forecast period. According to comprehensive projections, the market, valued at US$ 183.3 billion in 2020, is anticipated to surge at a substantial Compound Annual Growth Rate (CAGR) of 5% until 2032, reaching a staggering …
Pericarditis Treatment Industry Eyes a Valuation of US$ 6 Billion by 2032-FMI Projection
The global pericarditis therapeutics industry sales is projected to be worth US$ 3.60 billion in 2022 and US$ 6 billion by 2032, with a compound annual growth rate of 5.24%. The ageing of the population is expected to drive growth in this sector. The need for pericarditis medications will soar due to significant advancements in …
Ovulation Test Kit Industry Envisions a Reach of US$ 450 Million by 2032-FMI Projection
The ovulation test kits industry size is projected to grow at an annual rate of 8.6% to reach US$ 195 million in 2022 from an anticipated valuation of US$ 180 million globally in 2021. By 2032, the ovulation test kit market is estimated to be worth US$ 450 million, with a significant contributing factor expected …
Radiofrequency Balloon Catheter Industry Primed for Surge with a 5.5% CAGR between 2022 and 2032-FMI Projection
Using a multidisciplinary approach, Future Market Insights (FMI) concentrated on the growth and development of the radiofrequency balloon catheter industry share during the pandemic. The study offers insights into the market’s primary revenue revisions and current growth trends as of 2020, along with key takeaways for the duration of the predicted term. Future Market Insights …
X-ray Photoelectron Spectroscopy Industry Predicts Flourishing Future with a 6.9% CAGR by 2032-FMI Projection
The X-ray photoelectron spectroscopy industry is expected to grow at a compound annual growth rate (CAGR) of 6.9% during the projected period. The global demand for medical research is expanding, and factors including fewer medication errors, pure and safe medications, and technological advancements are driving the market for X-ray photoelectron spectroscopy. Government initiatives and assistance …
Global Microbial Gene Editing Services Industry is anticipated to achieve a remarkable US$ 30.5 Billion valuation by 2032, according to FMI’s study
The global microbial gene editing services industry demand is projected to be worth US$ 5.35 billion globally in 2022 and to increase at a CAGR of 19% to US$ 30.5 billion globally from 2022 to 2032. A technique called microbial gene editing allows for the modification of an organism’s DNA. The process of creating novel …
Micro Guide Catheters Industry Envisages a 5.6% CAGR Journey from 2022 to 2032-FMI Projection
The market for micro guide catheters industry share is projected to grow at a strong compound annual growth rate (CAGR) of 5.6% between 2022 and 2032. Given that people who are prone to cardiovascular disease or other conditions tend to lead sedentary lifestyles, it is expected that robust sales of micro guide catheters would rise …
Global Extended Release Drugs Industry is projected to achieve an 11% CAGR by 2032, prioritizing medication adherence according to FMI
The global extended release drugs industry size is a fast developing area with a key role to play in optimising medication adherence and patient outcomes. Extended release pharmaceuticals, sometimes referred to as sustained release or controlled release drugs, are made to release their active ingredients gradually over an extended period of time, typically 12 to …